Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60,026,563
-
Total 13F shares
-
18,046,261
-
Share change
-
+5,869,257
-
Total reported value
-
$248,653,190
-
Put/Call ratio
-
47%
-
Price per share
-
$13.80
-
Number of holders
-
90
-
Value change
-
+$81,737,278
-
Number of buys
-
61
-
Number of sells
-
21
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q3 2018
As of 30 Sep 2018 Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) had 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,046,261 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, FMR LLC, 683 Capital Management, LLC, SPHERA FUNDS MANAGEMENT LTD., CITIGROUP INC, Vanguard Group Inc, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., MANGROVE PARTNERS, and Knoll Capital Management, LP.
This table shows 90 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.